Equipoise Boldenone - E is used in medicine as a secondary aid when treating weakness and when it is desired to improve weight or apply organs.
This drug is contraindicated in patients with liver dysfunction, hypercalcemia, patients with a history of myocardial infarction (may cause hypercholesterolemia), pituitary insufficiency, prostate cancer, in selected patients with breast cancer, benign prostatic hypertrophy and nephrotic hypertrophy .
Anabolic agents are not indicated for use during pregnancy and are contraindicated due to the possibility of fetal masculinization.
The usual dose is 200-600 mg per week. The maximum dose is considered to be 600 mg per week. Injections with this medicine are painful, so they can be injected every 2 days.
Boldenone is a derivative of testosterone, but less androgenic than testosterone. This medicine helps to increase the number of red blood cells. The mechanism for this effect may occur by stimulating the erythropoietin stimulating factor. Autotestosterone release can be suppressed by inhibiting luteinizing hormone (LH). When administered in high doses, spermatogenesis can be blocked by inhibiting negative FSH feedback.
Patients suffering from liver dysfunction, hypercalcemia, with a history of myocardial infarction (may cause hypercholesterolemia), pituitary insufficiency, prostate carcinoma, in selected patients with breast cancer, benign prostatic hypertrophy and in the nephrotic stage of this nephrotic drug.
Boldenone causes a detrimental effect on testicular size, sperm production and quality in men. In women, the drug caused fewer total and large follicles, smaller ovaries, increased clitoral size, shortened estrus duration, decreased pregnancy rate and severely altered sexual behavior. It has the potential to cause liver toxicity.
If you suspect suspicion of overdose with boldenone undecylate, contact your doctor immediately.